Thanks to the medication class effects, multiple name brand medications are FDA-approved for: Assisting with type 2 diabetes management Reducing the risk of adverse cardiovascular events Helping with weight management At first glance, it may appear that semaglutide is not related to blood pressure
Check Your Eligibility If you are interested in exploring semaglutide, tirzepatide, or other GLP 1 based options, you can start by completing Mochis simple eligibility questionnaire
Connect with a GLP-1 dietitian covered by your insurance today
FDA-approved medications for obesity include phentermine, phendimetrazine, and diethylpropion for short-term use and phentermine-topiramate, naltrexone-bupropion, orlistat, and more recently the GLP-1RAs liraglutide and semaglutide, and the GLP-1/GIP dual receptor agonist tirzepatide for long-term use
When tirzepatide mimics the activity of the glucagon-like peptide-1 (GLP-1) hormone, it sends signals of fullness to the brain, which reduces hunger cravings and food noise
